Woman’s stage 4 endometrial cancer treated successfully with combination therapy

multicare.org·Sep 26

This story is reported by multicare.org. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Phase 3 Survival Data Show Combo Regimen Is a “Game Changer” for Ovarian Cancer

Oncology News Central·Apr 13

2

Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial

Nature·Jan 5

3

Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library

obgyn.onlinelibrary.wiley.com·Apr 16

4

3 recent advances in pancreatic cancer research

UT MD Anderson·Oct 9

5

Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights

Cureus·Jul 30

6

Immunotherapy’s Role in Treating Endometrial Cancer Expected to Grow

National Cancer Institute (.gov)·Apr 12

7

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

The New England Journal of Medicine·Mar 27

8

For Advanced Endometrial Cancer, Chemotherapy Plus Immunotherapy Improves Outcomes

Memorial Sloan Kettering Cancer Center·Mar 27